HPV vaccination uptake and administration from 2006 to 2016 in a commercially insured population of the United States.

ABSTRACT:

Background

Human papillomavirus (HPV) infection can cause various cancers and can be prevented through vaccination. The American Cancer Society (ACS) has set an HPV vaccination completion target in 13-year-old children to 80% by 2026. While HPV vaccine coverage (proportion ever vaccinated) estimates are available, annual uptakes (proportion initiating vaccine in a year) in the United States (U.S.) are not well-known.

Methods

We analyzed MarketScan® claims database to assess HPV vaccination uptakes in the U.S. among the 9- to 26-year-olds in 2006-2016. The annual uptake was the ratio of the number of enrollees who had a first record of an HPV vaccine during the year, and the number of enrollees of similar age and sex that year.

Results

Uptake was below 1% among childre

SUBMITTER: Prabhu VS 

PROVIDER: S-EPMC8422649 | biostudies-literature | 2021 Sep

REPOSITORIES: biostudies-literature